Explore Our Scientific Sessions at the 13th International Cancer and Medical Oncology Conference & Exhibition
Cancer research and medical oncology are advancing at an extraordinary pace. From immunotherapy and precision oncology to cancer genetics, biomarkers, early screening, and innovative treatment strategies, scientific progress is continuously transforming the way cancer is understood, diagnosed, and managed.
The 13th International Cancer and Medical Oncology Conference & Exhibition, organized by UCG, brings together researchers, oncologists, pathologists, clinicians, healthcare professionals, academics, industry experts, and innovators to exchange knowledge and explore emerging developments in cancer science. The conference is scheduled for February 1–2, 2027, at Novotel Al Barsha, Dubai, UAE, with a hybrid participation format. The event highlights the theme “Advancing Cancer Research, Diagnostics, and Precision Oncology” and offers 30 CME/CPD credits by The ACCME CME, according to the official conference website.
Explore the official CancerUCG Conference: https://cancer.ucgconferences.com/
A Scientific Program Covering the Full Spectrum of Cancer Care
The scientific program has been designed to address a broad range of subjects across cancer biology, diagnostics, treatment, prevention, and patient care. The official scientific tracks include 30 major areas, providing participants with opportunities to explore both established approaches and emerging developments in oncology.
1. Cancer and Medical Oncology
The scientific sessions begin with the fundamentals of cancer and medical oncology. Discussions in these areas can provide a comprehensive perspective on cancer biology, diagnosis, treatment approaches, systemic therapies, and developments shaping modern oncology practice.
Medical oncology remains a multidisciplinary field in which advances in diagnostics, therapeutics, molecular medicine, and supportive care increasingly influence clinical decision-making.
2. Immunotherapy
Immunotherapy has become one of the most important areas of modern cancer research. The conference scientific program includes a dedicated Immunotherapy track, providing a platform for discussion around approaches that harness the body's immune response against cancer.
Researchers and clinicians can exchange insights into evolving immunotherapeutic strategies, immune-based treatment approaches, challenges, and opportunities for improving cancer outcomes.
3. Radiotherapy and Chemotherapy
Radiotherapy and chemotherapy remain important components of cancer treatment. Dedicated sessions on both areas create opportunities to discuss developments in treatment strategies, clinical applications, treatment challenges, and approaches to improving patient care.
The scientific program also connects these treatment modalities with other areas of oncology, supporting a broader multidisciplinary understanding of cancer management.
4. Surgical Oncology
Surgical Oncology is another major scientific track. Sessions in this area focus on the role of surgery in cancer diagnosis, staging, and treatment.
The conference provides a forum where surgical oncology professionals can share research, clinical experiences, innovations, and perspectives on multidisciplinary cancer care.
5. Hormone Therapy and Leukemia
The scientific program also addresses specialized treatment and disease areas through dedicated tracks on Hormone Therapy and Leukemia.
Hormone-based approaches have an important role in the management of hormone-sensitive cancers, while leukemia research continues to evolve through advances in disease understanding, diagnostics, targeted approaches, and treatment.
6. Cancer Genetics and Epigenetics
Modern cancer research increasingly focuses on the molecular mechanisms responsible for cancer development and progression.
The conference includes dedicated tracks on Cancer Genetics and Cancer Epigenetics, creating opportunities to explore genetic mutations, molecular alterations, gene regulation, and the biological mechanisms that influence cancer.
These areas are particularly relevant to researchers and professionals interested in molecular oncology and personalized approaches to cancer care.
7. Tumor Microenvironment and Cancer Metastasis
Understanding the environment surrounding a tumor is essential to understanding cancer progression. The Tumor Microenvironment track examines the complex interactions between tumor cells and surrounding cellular and molecular components.
Another important scientific area is Cancer Metastasis, focusing on the mechanisms through which cancer cells spread from their original site to other parts of the body.
Together, these topics provide an important perspective on tumor progression, invasion, and disease development.
Spotlight on Major Cancer Types
A significant part of the scientific program is dedicated to specific cancer types. The conference tracks include:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Brain Tumors
Ovarian Cancer
Head and Neck Cancer
Pancreatic Cancer
Liver Cancer
Bone Cancer
These disease-focused sessions allow participants to explore research and clinical developments within specific areas of oncology.
For healthcare professionals, researchers, and academics, such focused sessions can provide opportunities to compare perspectives, present findings, discuss clinical challenges, and identify areas for future research.
Cancer Stem Cells and Biomarkers
The scientific program also explores two highly significant areas of cancer research: Cancer Stem Cells and Cancer Biomarkers.
Cancer stem cell research investigates specialized populations of tumor cells associated with self-renewal and differentiation capabilities. Understanding these cells may contribute to research into tumor development, treatment resistance, recurrence, and future therapeutic strategies.
Cancer biomarkers, meanwhile, can provide valuable biological information through analysis of blood, tissue, or other biological samples. Advances in biomarker research are increasingly relevant to cancer detection, diagnosis, prognosis, treatment selection, and monitoring.
Precision Oncology: Moving Toward Personalized Cancer Care
One of the central themes of modern oncology is personalization.
The Precision Oncology track reflects the growing importance of tailoring cancer management according to individual patient and tumor characteristics. Genomic sequencing, molecular profiling, biomarker analysis, and other advanced technologies are helping researchers and clinicians better understand differences between tumors.
At the conference, precision oncology provides an important scientific platform for discussing how advances in molecular medicine can contribute to more individualized approaches to cancer care.
Cancer Prevention, Epidemiology, and Screening
Cancer care is not limited to treatment. Prevention and early detection are equally important components of the fight against cancer.
The conference therefore includes dedicated scientific tracks on:
Cancer Prevention: Exploring strategies aimed at reducing cancer risk and addressing modifiable risk factors.
Cancer Epidemiology: Examining cancer patterns, risk factors, causes, trends, distribution, and outcomes across populations.
Cancer Screening: Focusing on approaches for identifying cancer or precancerous conditions at an earlier stage, particularly before symptoms develop.
These areas emphasize the importance of combining research, public health, early detection, and clinical medicine in the broader cancer-care ecosystem.
A Multidisciplinary Scientific Environment
One of the strengths of an international cancer and medical oncology conference is the opportunity to bring different professional perspectives together.
The CancerUCG program features speakers and contributors from areas including pathology, medical oncology, radiation oncology, laboratory diagnostics, research, surgery, pharmacology, imaging, survivorship, and other related disciplines. The published speaker list includes professionals from universities, hospitals, research institutions, laboratories, and healthcare organizations across different countries.
This multidisciplinary environment encourages knowledge exchange between professionals who approach cancer from different scientific and clinical perspectives.
Keynote Presentations, Speaker Sessions, Posters, and Panel Discussions
The scientific program is structured to provide multiple opportunities for knowledge sharing.
According to the published program, the event includes keynote introductions and speeches, speaker and poster presentations, panel discussions, and networking sessions across the two-day program. The schedule also includes exhibition opportunities and dedicated networking breaks.
Poster presentations can provide researchers and early-career professionals with an opportunity to showcase research findings, while panel discussions can encourage broader conversations around important challenges and developments in oncology.
Why Explore the Scientific Sessions?
The scientific sessions at the 13th International Cancer and Medical Oncology Conference & Exhibition are designed for professionals who want to stay connected with developments across the cancer research and oncology landscape.
Participants can benefit from:
Exploring emerging developments in cancer research
Learning about advances in oncology and cancer diagnostics
Understanding developments in precision oncology
Discussing immunotherapy and modern treatment approaches
Exploring cancer genetics, epigenetics, and biomarkers
Learning about developments across specific cancer types
Sharing research through oral and poster presentations
Connecting with international researchers and healthcare professionals
Building academic and professional collaborations
Discovering opportunities for research and industry collaboration
Who Should Attend?
The scientific program can be relevant to a broad professional audience, including:
Medical Oncologists
Radiation Oncologists
Surgical Oncologists
Pathologists
Cancer Researchers
Clinical Researchers
Hematologists
Molecular Biologists
Laboratory Professionals
Pharmacologists
Radiologists and Imaging Specialists
Healthcare Professionals
Academicians and Professors
Research Scholars and Students
Pharmaceutical and Biotechnology Professionals
Medical Device and Diagnostic Industry Professionals
Cancer Care and Survivorship Professionals
Connect, Collaborate, and Contribute
Beyond scientific presentations, an international conference provides an environment for professional networking and collaboration. Researchers can connect with peers working on related subjects, clinicians can exchange experiences, and industry professionals can explore emerging developments in cancer diagnostics, therapeutics, and technologies.
For researchers and academics, the conference also provides an opportunity to contribute to the scientific program through presentations and posters. Professionals interested in sharing their research can explore the conference's abstract submission opportunities.
Explore the Scientific Tracks: https://cancer.ucgconferences.com/tracks
Join the 13th International Cancer and Medical Oncology Conference & Exhibition
Cancer research is moving toward increasingly precise, personalized, multidisciplinary, and technology-driven approaches. Keeping pace with these developments requires continuous learning, scientific discussion, collaboration, and knowledge exchange.
The 13th International Cancer and Medical Oncology Conference & Exhibition aims to provide a global platform where professionals can explore developments across cancer research, medical oncology, diagnostics, treatment, prevention, and precision medicine.
Taking place on February 1–2, 2027, at Novotel Al Barsha, Dubai, UAE, the hybrid conference offers opportunities to participate in scientific sessions, keynote presentations, oral and poster presentations, panel discussions, networking activities, and exhibition engagement.
Whether you are a clinician, researcher, academic, healthcare professional, student, or industry representative, exploring the scientific sessions can help you discover new perspectives and connect with professionals working to advance cancer care.
Explore the scientific program, share your research, connect with global experts, and be part of the conversation shaping the future of cancer and medical oncology.
Conference: 13th International Cancer and Medical Oncology Conference & Exhibition
Date: February 1–2, 2027 Venue: Novotel Al Barsha, Dubai, UAE-Format: Hybrid
Theme: Advancing Cancer Research, Diagnostics, and Precision Oncology
CME/CPD: 30 CME/CPD Credits by The ACCME CME
#CancerConference #MedicalOncology #OncologyConference #CancerResearch #CancerCare #Oncology2027 #CancerTreatment #PrecisionOncology #CancerImmunotherapy #CancerDiagnostics #CancerAwareness #OncologyResearch #CancerMedicine #ClinicalOncology #SurgicalOncology #RadiationOncology #MedicalResearch #CancerBiomarkers #CancerGenetics #CancerPrevention #CancerScreening #TumorResearch #CancerExperts #OncologyProfessionals #HealthcareConference #MedicalConference #ScientificSessions #CancerInnovation #DubaiConference
Comments
Post a Comment